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PREFACE
Aims of the Study
Until recently minimal insight involving the role of macrophages in peritoneal wound
healing has been achieved.

The objective of this study is to determine the role that

macrophages play in the development of post-operative adhesions. The central hypothesis is
that surgical-induced hypoxia triggers a pro-inflammatory signal, leading to the activation and
recruitment of resident and infiltrating macrophages to traumatized tissue. This hypothesis has
been formulated on the basis of strong preliminary and published data, which suggest that
hypoxia plays a major role in the development of the adhesion phenotype, an integral part to
post-operative adhesion development (1, 11-16, 28-34). This phenotype is characterized by a
reduction in plasminogen activator activity, increased extracellular matrix deposition, increased
cytokine production, and reduced apoptosis (1, 11-16).

Furthermore, we have shown that

exposure of normal peritoneal fibroblasts to hypoxia, irreversibly induces the adhesion
phenotype (1, 28-34). The rationale for this study is that hypoxia, through the induction of HIF1and TGF-1 expression, induces the expression of TGF-1, type I collagen and VEGF, not
only in fibroblasts but also in macrophages.
We examined the hypothesis by pursuing three specific aims:
1. Determine whether macrophages express adhesion phenotype markers TGF-1,
type I collagen and VEGF, and whether this expression is induced by hypoxia.
2. Determine whether the adhesion phenotype is induced in macrophages through a
HIF-1 dependent mechanism following hypoxia exposure.
3. Determine whether human macrophages stimulate normal peritoneal fibroblasts to
acquire the adhesion phenotype following hypoxia exposure.

xii

Collectively, the outcome from this study will support the role of macrophages in the
development of the adhesion phenotype and thus may involve an important role of innate
immunity in the pathogenesis of post-operative adhesion development.

xiii
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CHAPTER 1
Introduction
Post-operative Adhesions
Post-operative adhesion development remains a very frequent occurrence that is often
unrecognized by physicians due to the limited ability to conduct early second-look surgeries.
We and others have had the opportunity to perform such studies and found that nearly 85% of
patients examined developed adhesions (1, 2). Adhesions are abnormal fibrous connections that
develop between tissues and organs as a result of inflammation, but most frequently as a sequel
to surgical trauma.

Consequently, adhesions are the major contributors to small bowel

obstruction, infertility, and severe pelvic and abdominal pain (1-3). Managing adhesions and
their related complications affects the health-care system drastically.

The prolongation of

hospital stay, readmissions, surgical intervention, and potential litigation impose an enormous
economic burden (4).

Within the United States alone, adhesion-related issues, cost the

healthcare system over $2.24 billion annually (1, 2). Therefore, adhesions are considered the
most frequent and costly problem associated with surgery (3).
In spite of the current use of less traumatic surgical methods, including microsurgical and
laproscopic techniques, a high incidence of adhesion development persists. Laparoscopic lysis
of adhesions is optional for patients experiencing chronic adhesion-related pelvic pain, though
adhesions have been shown to reform at one or more sites in almost all patients who undergo
adhesiolysis, and at over two-thirds of the actual sites where adhesiolysis was performed (5-7).
Having awareness of the many reasons to address the problem of adhesions, and the large
number of surgical procedures performed each day in the United States, our understanding of
peritoneal healing is extremely limited. However, one thing stands out: some patients heal
adhesion-free, while others develop severe scarring from seemingly equivalent procedures. The
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basis for this difference is completely unknown.

Our understanding of these findings has

focused our attention to better understanding molecular mechanisms responsible for adhesion
development. Improved understanding of these mechanisms may allow clinicians to inhibit or
selectively limit the development of post-operative adhesions.
Healing of the Peritoneum
In order to better understand mechanisms involved in the pathophysiology of peritoneal
wound healing and postoperative adhesion development, we must first examine the anatomy of
the normal peritoneum. The peritoneum is a serous membrane that lines the abdominal cavity
and consists of mesothelial cells whose primary function is to ensure free movement of
abdominal structures. In doing so, mesothelial cells produce a lubricating fluid to minimize
friction within the peritoneal cavity.

Trauma to the peritoneum resulting from infection,

inflammatory disease, and/or surgical procedures, disrupts this activity and promotes adhesion
development. Subsequently, healing in the presence/absence of adhesions is determined by four
sequential, yet overlapping phases; these include blood homeostasis, inflammation, cell
proliferation, and tissue remodeling (1, 8). Mesothelial cells, fibroblasts, inflammatory, and
immune cells are integral to these processes (3). Substances released from these cells regulate
fibrinolytic activity, tissue remodeling, angiogenesis, and extracellular matrix turnover,
processes that are central to the development of post-operative adhesions (1).
While many phases of peritoneal wound healing resemble dermal wound healing, two
fundamental differences exist. First, in contrast to dermal injuries, which heal from the edges
toward the middle (such that time of healing is dependent on the surface area of the lesion),
peritoneal injuries are thought to heal by differentiation of underlying progenitor cells (such that
healing occurs throughout the lesion simultaneously) (1, 9). Second, peritoneal wounds are
continuously exposed to factors present in the peritoneal fluid, such as growth factors and
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cytokines (1, 10). These substances are released from various cells that are resident to the
wound; therefore, an autocrine/paracrine feedback is an important component of peritoneal
healing. For normal peritoneal healing to occur, optimal concentrations of these signaling
molecules must be present. Therefore, inhibition or over-stimulation may lead to impairment
(nonhealing) or excessive scar tissue (adhesions).
The Adhesion Phenotype
To date, approaches to limit adhesion development have primarily focused on minimizing
surgical trauma such as meticulous attention to operative techniques, delicate purposeful tissue
handling, and uncompromising hemostasis. Another approach utilizes internal barriers, such as
Seprafilm (Genzyme, Cambridge, MA), Interceed (Gynecare, Somerville, NJ), and Adhesion
reduction Solution (ADEPT; Baxter BioSurgery, Deerfield, IL), to separate surgically injured
tissue from non-injured tissue surfaces during the initial postoperative timing period while
remesothelialization is occurring, a process that is usually expected to take 3 to 5 days (4). Over
time these approaches have not been completely effective in reducing adhesion development
therefore additional research focusing on mechanisms involved in peritoneal wound healing is
critical. Delineating mechanisms that are paramount to peritoneal healing may provide a more
successful approach for adhesion prevention. Our laboratory has a long-standing interest in
studying molecular mechanisms involved in the pathogenesis of postoperative adhesions. We
have established primary cultures of fibroblasts isolated from normal peritoneum and adhesion
tissues (from the same patients) and characterized differences between these two cell lines at the
molecular level (1, 11). Adhesion fibroblasts, when compared to normal peritoneal fibroblasts,
exhibit a reduction in plasminogen activator activity (lower tPA and higher PAI-I), increased
angiogenesis (increased VEGF), increased extracellular matrix deposition (higher type I collagen
and fibronectin), increased cytokine production (higher TGF-1), and reduced apoptosis (higher
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Bcl and lower Bax), collectively known as the “adhesion phenotype” (1, 11-16). Additionally,
we have established an animal model as well as an ex vivo model to further investigate molecular
mechanisms in vivo.
Hypoxia and Oxidative Stress
Recently, we have gathered an immense amount of compelling evidence to support the
hypothesis that surgical-induced hypoxia is the initiating factor leading to post-operative
adhesion development. In support of this hypothesis, we have shown that hypoxia irreversibly
induces the adhesion phenotype in normal peritoneal fibroblasts (1, 17-23).

However, the

mechanism by which hypoxia acts is not fully understood. During the first five minutes of
hypoxia, there is a significant production of free radicals, either through an increase in reactive
oxygen species (ROS) or by decreasing ROS scavengers (24-28). This increase in ROS has
significant consequences, such as stimulation of cellular proliferation, promotion of mutations
and genetic instability, and ultimately, alteration in both the phenotype and genotype (24, 29-30).
We have shown that hypoxia-generated superoxide (O2●−), a potent reactive oxygen
species (ROS), induces the development of the adhesion phenotype (31). Under normoxic
conditions, ROS are maintained at optimal levels by specific scavenging systems (31-33). This
process is achieved by various enzyme systems that neutralize toxic oxidants, such as ROS.
Superoxide dismutase (SOD), an anti-oxidizing enzyme, catalyzes the conversion of superoxide
(O2●−) to hydrogen peroxide (H2O2), which subsequently leads to the conversion of water by
catalase or glutathione (GSH) peroxidase coupled with glutathione reductase. We have shown
that scavenging O2●−, by superoxide dismutase (SOD), restores adhesion markers in adhesion
fibroblasts to levels observed in normal peritoneal fibroblasts (31). Also, scavenging O2●− by
SOD during hypoxia exposure inhibits the development of the adhesion phenotype in normal
peritoneal fibroblasts. Similarly, a role for ROS has been established in adhesion formation
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which is derived from the observation that ROS scavengers reduce adhesion formation following
open surgery in different animal models (30). It has been shown that SOD reduces adhesion
formation induced by vascular obstruction/reperfusion of an ileal segment in rats (30). Based on
these observations and others we have concluded that hypoxia, through the production of ROS,
plays a significant role in the pathogenesis of postoperative adhesion development.

More

specifically, acute oxidative stress in the peritoneum induces mesothelial cell loss or dysfunction,
peritoneal fibrosis, and more importantly intra-abdominal adhesion formation (34).
Homeostatic Response to Hypoxia: HIF-1
Hypoxia initiates transcription of a number of genes that help to sustain O2 supply to
tissues and to enhance cell survival during severe O2 deprivation. One of these classic cellular
adaptations to ensure O2 availability is the manifestation of hypoxia-inducible factor-1alpha
(HIF-1) (35).

Hypoxia-inducible factor (HIF) is a major transcriptional regulator of cell

metabolism and stress caused by oxygen deficiency (hypoxia) (35). The significance of HIF was
recently demonstrated by a significant decrease in mRNA expression of vascular endothelial
growth factor (VEGF) and glycolytic enzymes seen during hypoxia in HIF-1-deficient murine
embryonic stem cells (36-38). At the tissue level VEGF stimulates the formation of new
capillaries and at the cellular level glycolytic enzymes and glucose transporter 1/3 (GLUT1 and
GLUT3) gene products are enhanced (36-38).
The HIF protein is composed of two subunits, an oxygen-sensitive HIF-1 subunit and a
constitutively expressed HIF-1β subunit. Therefore, HIF-1 expression, and thus the formation
of the HIF-1-HIF-1 complex, is largely dependent on O2 availability (Diagram 1). Activity of
the HIF-1/HRE pathway, under optimal oxygen conditions, is substantially suppressed by the
activity of prolyl hydroxylases (PHD) which modify HIF-1 at specific prolyl and asparingyl
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amino acid residues (35-37, 39-41).

This

results in polyubiquitination of HIF-1 by
von Hippel-Lindau tumor suppressor protein
(VHL) (35-37).

Ultimately, the HIF-1

subunit undergoes proteasomal degradation
and is unable to form the heteromeric, HIF
complex.

Post-translational modifications

(hydroxylation) are inhibited during hypoxia
(35).

Unmodified HIF-1 is then able to

migrate to the nucleus and bind HIF-1(35).
The HIF-1/HIF-1 complex stabilizes and
goes on to regulate HIF-dependent gene
expression.

Upon complex formation HIF

controls transcription by associating with
hypoxia response elements (HREs) in the
promoter region of a wide array of genes (3537).

HIF-controlled pathways influence

metabolism, angiogenesis, cell differentiation,
and apoptosis, and also have implications for

Diagram 1: Stability and Transcriptional
Activity of HIF-α. In the presence of O2 and
cofactors, Fe+2 and 2-OG, PHDs hydroxylate
HIF-1α. Modified HIF-1α recognized by the
E3 complex that is followed by E2/E1mediated ubiquitylation and degradation in the
26S
proteasome.
FIH-1-mediated
Nhydroxylation prevents recruitment of
p300/CBP transcriptional coactivators. In the
absence of O2, PHDs and FIH-1 are
inactivated. Inmodified HIF-1α translocates to
the nucleus, dimerizes with HIF-β, recruits
p300/CBP, and induces the expression of its
target genes via binding to the HRE. BTM,
basic transcriptional machinery; E1, ubiquitinactivating enzyme; E2, ubiquitin-conjugating
enzyme; E3, ubiquitin ligase; FIH-1, factor
inhibiting HIF-1; HRE, hypoxia-response
element; 2OG, 2-oxoglutarate; PHDs, prolyl
hydroxylases; Ub, ubiquitin; VHL, von
Hippel-Lindau protein. (93)

normal physiology and development (35-37).
ROS have been proposed to participate in the signal transduction process mediating the
stabilization of HIF-1 during hypoxia (42). Under hypoxic conditions, mitochondria participate
in a ROS burst (42). When the partial pressure of oxygen is reduced, electrons bind to molecular
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oxygen, forming superoxide (O2●−) (42). Superoxide is then converted to H2O2 by SOD. The
resulting H2O2 efflux into the cytosol exerts an inhibitory effect on PHD activity, allowing
HIF1α to accumulate, dimerize with HIF1β, and translocate into the nucleus where it modulates
the expression of genes that favor survival under hypoxic conditions (42).
The Role of Cytokines: TGF-1
In addition to HIF-1 transforming growth factor beta (TGF-) also plays a predominant
role in peritoneal wound healing. Under normal conditions TGF- regulates inflammation,
angiogenesis, and extracellular matrix (ECM) turnover (43-47). Excessive TGF- exposure
exaggerates these processes thus promoting the development of adhesions (43). We have shown
that hypoxia significantly increases the expression of TGF- isoforms and their receptors in
multiple cell types (28, 30, 48-50). Hypoxia-induced TGF-1 expression has been shown to
control the stability of HIF-1α through the regulation of prolyl hydroxylase (52). In addition,
TGF-β1 can influence the accumulation of HIF-1α in normoxic conditions which further
exacerbates TGF-1’s ability to promote adhesions even following reoxygenation (52).
Transforming growth factor  (TGF-) exists in three isoforms (TGF-1, TGF-2 and
TGF-3). Practically all cells have receptors for the TGF-s, and at least one of the isoforms is
produced in all tissues (53-57). Unlike other cytokines, TGF- is secreted in a latent form. TGF and the non-covalently bound latency-associated peptide (LAP; derived from the N-terminal of
the TGF- precursor), must be released for activation. Therefore, several possible modes of
activation exist. It is thought that proteolysis by plasmin and other proteases is an important
mechanism (53-57). LAP-TGF- is usually secreted as a large latent complex consisting of
LAP-TGF- covalently bound to a latent TGF--binding protein (LTBP). LTBPs serve as
structural components of the ECM and modulators of TGF- availability.
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TGF- reecptors have three components: type I (RI, or ALK5); type II (RII) and type III
(RIII, or β-glycan). RIII binds TGF- (all isoforms) and recruits TGF- to RII, which then
phosphorylates RI to form a heterotetrameric serine/threonine kinase complex. In turn, RI
phosphorylates Smad2 and Smad3 (receptor-associated Smads (R-Smads)), and the latter form a
heteromeric complex with Smad4, which translocates to the nucleus, binds to DNA and regulates
transcription. In contrast to Smads 2-4, Smad7 inhibits TGF- signaling.
Diagram 2: Activation of R- and Co-Smads. Upon
ligand-induced heteromeric complex formation and
activation of type I and type II receptors, R-Smads
are phosphorylated and form heteromeric complexes
with Co-Smads that translocate into the nucleus,
where they control the expression of target genes in a
cell type specific manner. Nonactivated Smads can
be retained in cytoplasm through association with
microtubules (MT). The recruitment of Smad2 to the
TGF- receptor complex has been shown to involve
a FYVE domain containing protein termed Smad
anchor
for
receptor
activation
(SARA).
Transcriptional modulation by Smads is achieved
through complex formation with, e.g. transcriptional
coactivators like p300/CBP and interacting
transcription factors. R- and Co-Smads appear to
form preferentially trimers consisting of one CoSmad and two R-Smads. However, Smad complexes
with other stoichiometry cannot be excluded (94).

Diagram 3: Mechanism of Action of I-Smads
Negative regulation of TGF-/Smad signaling can
occur through I-Smads that prevent activation of RSmads or compete with Smad4 for heteromeric
complex formation with activated R-Smads. ISmads are induced by TGF- family members and
they may thus participate in a negative feedback
loop (94).
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The Role of Angiogenesis: VEGF
Stimulation of cells with TGF- can result in the activation or inhibition of several genes
including VEGF, a major angiogenic growth factor (53-57). Angiogenesis is involved in the
restructuring process following tissue injury by regulating regeneration of capillaries, from preexisting vasculature, to compensate for the loss of nutrients and oxygen (1, 8-10, 58-60).
Capillaries are needed in all tissues for exchange of nutrients and metabolites. Changes in
metabolic activity, as a result of tissue trauma, leads to proportional changes in angiogenesis and
hence, proportional changes in capillarity (58-60). Oxygen plays a pivotal role in this process.
More specifically, hypoxia potentiates angiogenesis, in part, by increasing both HIF-1 and
TGF-1 levels subsequently leading to the up-regulation of VEGF (1, 45, 61-66). Additionally,
VEGF stimulates endothelial cell proliferation and increases vascular permeability.
Most control systems of the body, including
angiogenesis, act by a negative feedback mechanism.
When oxygenation is inadequate, the tissues become
hypoxic, and this hypoxic signal induces or suppresses
various proangiogenic or antiangiogenic substances (69).
The increase in neovascularization promotes oxygen
delivery to the tissue thereby increasing both capillary
surface area and maximum blood flow to the tissues, and
decreasing diffusion distances between capillaries (69).
When oxygen levels normalize, proangiogenic and
antiangiogenic factors return to normal levels and

Diagram 4: Regulation of
Angiogenesis during Hypoxia.
HIF-1 and TGF-1 activates
VEGF to stimulate angiogenesis
during hypoxia. Over expression
of
VEGF
favors
adhesion
formation.

development of the vasculature is minimized, thereby closing the feedback loop (69).
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Excessive vascularization promotes adhesion development therefore, therapeutic
applications targeting angiogenic pathways, specifically VEGF, have potential to reduce
peritoneal adhesions (67, 68). For example, Bevacizumab has been shown to decrease adhesion
formation following laparotomy in rats by blocking VEGF receptor occupancy (68). Binding of
VEGF to its respective receptor results in receptor dimerization and ligand-dependent receptor
tyrosine kinase phosphorylation, thereby activating intracellular signaling pathways involved in
endothelial cell proliferation, migration, survival, sprouting, and tube formation, as well as upregulation of molecules involved in degradation of the extracellular matrix.
The Role of the Extracellular Matrix: Type I Collagen
The earliest event in tissue repair involves deposition of fibrin-rich exudates, also
referred to as provisional matrix (1). This process is critical to the initiation of peritoneal wound
healing, though its resolution is also essential to healing without adhesions. Fibrin functions to
restore injured tissues, and under normal circumstances are only temporary (29, 70-72). Lack of
fibrin degradation allows the provisional matrix to become more organized which results in
vascularization (increased VEGF) and collagen deposition. The organization of these fibrin
bands over time and their transformation into mature fibrous adhesions is what allows adhesions
to persist. The fibrinolytic pathway is responsible for degrading these filmy, fibrinous adhesions
though following surgery this pathway is limited due to decreased blood supply (29, 70-72).
Plasminogen activators convert plasminogen to plasmin, and are inhibited by plasminogen
activator inhibitor (PAI). Plasmin degrades fibrin and also activates collagenases which go on to
degrade type I collagen. We have shown that hypoxia, in addition to TGF-1, decreases the
fibrinolytic pathway by increasing PAI expression while decreasing PA expression (29, 70-72).
In addition to the PA/plasmin system the outcome of normal wound healing or
impairment, such as adhesion development, largely depends on extracellular matrix turnover.
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Type I collagen is the most abundant extracellular matrix protein. Several studies have shown
Tissue Insult: Hypoxia

Release of cytokines, growth
factors, others
Persistent fibrinous
mass

Resolution of fibrinous
mass

Fibrin deposition

No adhesions formed

Fibrous clot-like adhesions
form (3-5 days)

Adhesions formed

Diagram 5: Normal vs. pathologic conditions of peritoneal wound healing. Surgery
causes damage to the mesothelium and results in a hypoxic microenvironment. Hypoxia leads
to accumulation of a proteinaceous exudate at the injured site. These factors regulate fibrin
deposition and are responsible for driving the recruitment of multiple cell types, such as
fibroblasts, mesothelial cells, and macrophages, to the injured site. The earliest event in tissue
repair involves deposition of fibrin-rich exudates, also referred to as provisional matrix. This
process is critical to the initiation of peritoneal wound healing, but its resolution is also
essential to healing without adhesions. Fibrin functions to restore injured tissues and under
normal circumstances is only temporary. The fibrinolytic pathway is responsible for
degrading these filmy, fibrinous adhesions though following surgery this pathway is limited
due to decreased blood supply. Lack of fibrin degradation allows the provisional matrix to
become more organized. The organization of these fibrin bands over time and their
transformation into mature fibrous adhesions is what allows adhesions to persist.
that over-expression of type I collagen leads to adhesion formation (28). Hypoxia and hypoxiainduced TGF-1 expression enhance type I collagen expression and therefore promote
conditions favorable for adhesion development (30, 73-76). Matrix metalloproteinases (MMPs)
degrade various components of the ECM, including type I collagen, and are induced in tissues
undergoing extensive remodeling, as seen during inflammation and wound healing.

The
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proteolytic activity of MMPs is inhibited by tissue inhibitor of matrix metalloproteinases
(TIMPs), which also influences cell growth, angiogenesis, and tumor invasion. Therefore the
balance between the expression of MMPs and TIMPs is critical to normal wound healing. In
general, hypoxia inhibits the expression of MMPs and increases TIMPs, thus decreasing matrix
degradation and increasing fibrosis (73-76). Furthermore, hypoxia-induced TGF-1 expression
decreases MMPs which furthers minimizes the proteolytic ability of MMPs to maintain overexpressed ECM factors, such as type I collagen, following tissue injury (30, 73-76).
Factors involved in the fibrinolytic pathway and ECM turnover have been popular targets
in reducing adhesion development (70, 74-75, 77). For example, Interceed, an adhesion barrier,
reduces the incidence, extent, and severity of adhesions by physically separating tissue layers
during the healing process. We have shown that Interceed increases the expression of PA and
the PA/PAI ratio thereby promoting dissolution of fibrin which highlights Interceed’s role as a
barrier as well as having biologic effects (70). On the other hand, Tisseel, a fibrin sealant,
facilitates initiation of coagulation at the wound site and thereby restores tissue stability by
ensuring hemostasis. We have shown that Tisseel enhances the expression of MMPs while
reducing TIMP expression (74-75). Collectively, these observations demonstrate the ability of
internal tissue barriers to successfully reduce post-operative adhesion development thus
implicating the importance of factors involved in tissue remodeling.
A Proposed Role of Macrophages in Adhesion Development
Until recently minimal insight involving the role of macrophages in peritoneal wound
healing has been explored. Macrophages are evolutionarily ancient cells deriving from the
primordial amoeba that evolved in the hypoxic atmosphere and adapted to normoxic conditions.
Consequently, macrophages are highly versatile cells that are able to function under adverse,
environmental conditions, such as hypoxia. Extensive monocyte extravasation is an early event
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in the onset of inflammation and wound healing (78-81). Chemo-attractants, released in the
environment as a result of inflammation, establish chemo-tactic gradients that are responsible for
driving the recruitment of macrophages within avasular and necrotic, hypoxic areas of diseased
tissue (80-81). Macrophages travel toward injured tissue as monocytes released from systemic
circulation and subsequently undergo a process of differentiation and activation. Hypoxia is
known to induce marked changes in the secretory activity of macrophages thereby eliciting
cellular processes including, angiogenesis, ECM turnover, inflammation, and phagocytosis (7879). The objective of this study is to determine the role of macrophages in the development of
post-operative adhesions.
Materials and Methods
Cell cultures
Macrophages: Macrophages, from a human macrophage cell line, EL-1 (American Type
Culture Collection Global Bioresource Center Manassas, Virginia), was cultured in Iscove’s
Modified Dulbecco Medium supplemented with 10% fetal bovine (FBS) and 2% penicillin and
streptomycin. The next day macrophages were centrifuged for 5 min at 1800 RPM. Old media
was discarded and macrophages were re-suspended in 10 mL of PBS buffer and re-centrifuged.
Macrophages were transferred into a fresh 100 mm cell culture dish with pre-warmed media and
placed in a 37°C incubator (95% air and 5% CO2). Once confluence was reached dishes were
sub-cultured (1:3 split ratio).

Studies were conducted using passages 3-5 to maintain

comparability to ensure normal phenotype of cells was not compromised. Based on previous
experience with these cells, variability is observed following splitting of cells more than 5 times.
Fibroblasts: Collection and isolation of fibroblasts have been previously described (1).
At the initiation of surgery adhesion tissue and normal parietal peritoneal tissue from the anterior
abdominal wall lateral to the midline incision were excised from patients undergoing laparotomy
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for pelvic pain, following entry into the abdominal cavity (1). Normal peritoneum was at
minimum three inches from any adhesions. Subjects did not have an active pelvic or abdominal
infection and were not pregnant. All patients gave informed written consent to tissue collection,
which was conducted under a protocol approved by the Wayne State University Institutional
Review Board.
Harvested tissue samples from five women were immediately placed in standard media
[Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS), 2%
penicillin and streptomycin]. Tissues were cut into small pieces in a sterile culture dish and
transferred into another fresh T-25 flask with 3 ml of dispase solution (2.4 U/ml; GIBCO BRL,
Invitrogen Corporation, Life Technologies, Carlsbad, California). The flasks were incubated
overnight at 37°C in an environ-shaker (LAB-LINE Instruments, Barnstead International,
Dubuque, Iowa). The samples were then centrifuged for 5 min at 1400 g, transferred into a fresh
T-25 flask with pre-warmed DMEM and placed in a 37°C incubator (95% air and 5% CO2);
outgrowth of fibroblasts generally took 2 weeks. Once confluence was reached, the cells were
transferred to 90 mm tissue culture dishes and cultured in standard media with 10% FBS.
Thereafter, the confluent dishes were sub-cultured by trypsinization (1:3 split ratio). Studies
were conducted using passages 3-5 to maintain comparability to ensure normal phenotype of
cells was not compromised.

Based on previous experience with these cells, variability is

observed following splitting of cells more than 5 times.
Lipofectamine-siRNA Transfection
Macrophages (2.5 X 105) were seeded in a 6-well dish (Becton Dickinson, Franklin
Lakes, NJ) transfected with 5 L of Lipofectamine RNAiMAX Reagent (Invitrogen, Carlsbad,
CA; catalogue no. 13778-075) complexed with 150 picomoles of a specific siRNA (HIF-
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1TGF-1) in standard medium without antibiotics.

Macrophages were then placed in a

standard tissue incubator (37°C; 95% air and 5% CO2) for 24-hrs.
siRNA Design, Synthesis, and Labeling
Small interfering RNAs were designed after determination of target sequences by
aligning specific sequences (HIF-1TGF-1) to an Ambion Web-based algorithm.

The

nucleotide duplex siRNA molecules with 2-dTdT overhangs, were resuspended in nuclease-free
water according to the instructions of the manufacturer (Ambion). To ensure a stringent control,
a scrambled control sequence was obtained from Ambion (Silencer Negative Control No. 1
siRNA; catalogue no. 4611).
TGF-1 treatment
TGF β 1 (2g) human recombinant was purchased from Sigma-Aldrich and dissolved in
phosphate buffered saline containing 2 mg/mL bovine serum albumin to reach a concentration of
20 g/mL. Working concentrations (0, 375, 750, 1500 ng TGF-1/mL media) were prepared by
further diluting the stock solution.
Hypoxia Treatment
Hypoxic experiments were performed in an airtight modular incubator chamber. The
chamber was deoxygenated by positive infusion of 2% O2 in a CO2-nitrogen gas mixture for 15
minutes. Cultures were then placed in a standard humidified tissue incubator. There were no
statistically significant differences in viability by crystal violet or trypan blue exclusion (data not
shown). Parallel cultures were placed in normoxic conditions for all experiments. Cells were
harvested after 24 hrs. All experiments were performed in triplicate.
Real-Time RT-PCR for HIF-1, VEGF, TGF-1, and type I collagen
The real-time RT-PCR technique was used to detect and compare mRNA levels for each
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experiment. The advantage of the real-time RT-PCR method over the conventional PCR method
is that it allows the determination of the absolute copy number of mRNA.
RNA isolation
Total RNA was extracted from normal peritoneal fibroblasts and macrophages using an
RNeasy Mini Kit (Qiagen, Valencia, CA) according to the protocol provided by the
manufacturer.
Reverse transcription
A 20uL cDNA reaction volume was prepared with the use of QuantiTect Reverse
Transcription Kit (Qiagen), as described by the manufacturer’s protocol.
Real-time RT-PCR analysis
Optimal oligonucleotide primers for real-time RT-PCR amplification of reversetranscribed cDNA were selected with the aid of a commercial software program (Beacon
Designer 7.0; Premier Biosoft, Palo Alto, CA). Human oligonucleotide primers, which amplify
variable portions of the protein coding regions, are summarized in Table 1 below.
Table 1: Human Oligonucleotide Primers
Product
length
142

Locus

Sense (5’-3’)

Antisense (3’-5’)

TGF-1

AGTGGTTATCTTTTGATGTC

GTAGTGAACCCGTTGATG

VEGF

GGAAACCAGCAGAAAGAGG

AAGCAGGTCACTCACTTTG

132

Type I Collagen

CCTGTAAACTCCCTCCATCC

AAGTCCATGTGAAATTGTCTCC

133

HIF-1

AGCCGAGGAAGAACTATGAAC

ACTGAGGTTGGTTACTGTTGG

100

Real-time RT-PCR was performed with a QuantiTect SYBR Green RT-PCR Kit
(Qiagen) and a Cepheid 1.2f Detection System (Cepheid, Sunnyvale, CA). Reactions are 25-L
volumes including 12.5 L of 2× QuantiTect SYBR Green RT-PCR Master Mix, 1 L of cDNA
template, and 0.2 mol/L of each target-specific primer that were designed to amplify a portion
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of each gene. To quantify each target transcript, a standard curve was constructed with a 10-fold
dilution series of a standard plasmid. The three-step PCR protocol applied for HIF-1, VEGF,
TGF-1, and type I collagen reactions consists of 45 cycles of 95°C for 15 seconds, 60°C (HIF1), 57°C (VEGF), 52°C (TGF-1), 58°C (type I collagen) for 30 seconds, and 72°C for 30
seconds. After PCR, a melting curve analysis will be performed to demonstrate the specificity of
the PCR product as a single peak.
Immuno-precipitation and Western Blot Analysis
An antibody for HIF-1, VEGF, TGF-1, and type I collagen was incubated with
nuclear/cytoplasmic protein extracted from normal peritoneal fibroblasts and macrophages. The
antibody/antigen complex was pulled out of the total protein sample using protein A/G-coupled
agarose beads. The sample was combined with Tris-Glycine SDS Sample Buffer (Invitrogen
LC2676) and heated to 85ºC for 5 minutes to unfold the protein. Proteins were separated on a 420% Tris-Glycine gel (Invitrogen) at 130V for 180 minutes against a molecular weight ladder.
Proteins were transferred from the gel to a nitrocellulose membrane using an electroblotting
apparatus at 40V for 2 hrs.
Non-specific protein binding was blocked by incubating the membrane for 30 min in 5%
non-fat milk solution. Membranes were washed 1X with wash buffer. Primary antibody diluted
in 1% non-fat milk solution for HIF-1, TGF-1, VEGF, type I collagen, and tubulin primary
antibodies were incubated for 24 hrs at 4ºC. Membranes were washed 4X in wash buffer and
incubated for 1 hr at room temperature, with horse-radish peroxidase (HRP)-conjugated
secondary antibody, in 2% non-fat milk. Membranes were submerged in a chemiluminescence
reagent (Millipore) for 5 min and developed. Protein bands were scanned and analyzed by NIH
image J 3.0.
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Statistical Analysis
Real-time RT-PCR and Western blot data was analyzed using paired t-tests. Statistically
significant differences for comparison of means were established at P<0.05. All statistical
analyses were performed using prism 4.0 for Windows.
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CHAPTER 2
Hypoxia Induces the Adhesion Phenotype Markers in Human Macrophages
Introduction
Emerging evidence suggests that macrophage dysfunction is an integral component of the
pathogenesis of wound healing (78-81).

As a result, increased understanding of this

multifunctional cell is an attractive therapeutic target to limit or prevent post-operative adhesion
development. The objective of this study is to determine whether human macrophages express
adhesion phenotype markers TGF-1, type I collagen and VEGF, and whether this expression is
induced by hypoxia exposure.
It is well known that macrophages accumulate in poorly perfused, hypoxic sites, where
comparable damage has occurred.

Inflammation is a prerequisite for healing and there is

compelling evidence linking TGF-β production to wound macrophages and adhesion formation
(82). As mentioned previously, TGF-1 plays a role in chemotactically recruiting multiple cell
types to the site of injury, including macrophages and fibroblasts, regulating angiogenesis, as
well as extracellular matrix turnover (43-47). Therefore, macrophages may mediate multiple
wound healing processes through their production in TGF-1 alone. Additionally, macrophages
are well documented to produce abundant amounts of VEGF and therefore are considered to
have pro-angiogenic capabilities following tissue trauma (82-84). We hypothesize that hypoxia
will induce significant changes in macrophage expression of the adhesion pehonotype markers.
The rationale of this study is derived from extensive data from our laboratory and others
indicating that hypoxia exposure irreversibly induces the development of the adhesion phenotype
in fibroblasts (1, 28-34). The significance of this aim is that macrophages represent a role not
only for protecting tissues from invading pathogens and toxicants but also for initiating and
promoting the development of post-operative adhesions. Understanding the role of macrophages
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in the pathogenesis of post-operative adhesions may lead to the development of better and more
efficacious approaches for treating and/or preventing adhesion development.
Design
To accomplish this aim, we measured the levels of select adhesion phenotype markers in
macrophages following hypoxia exposure. Macrophages (1.0 X 107 cells) were cultured in 10
mL of standard media [Dulbecco’s modified media supplemented with 10% fetal bovine serum
(FBS) and 2% of streptomycin and penicillin] under normal (20%O2) and hypoxic (2% O2)
conditions, for 24 hrs. After 24 hr incubation macrophages and media were centrifuged at 1800
RPM for 5 min. Macrophages were collected from normal and hypoxic cultures, protein and
RNA extracted, cDNA synthesized, and analysis performed.
Real-time RT-PCR was utilized to measure mRNA levels for TGF-1, type I collagen,
and VEGF. This method is well established in our laboratory and all primer sets for each gene
target have been validated. Additionally, western blot analysis was utilized to correlate TGF-1
and VEGF protein with mRNA levels. Collectively, this experimental design should yield
insight into the expression of the adhesion phenotype markers, by macrophages, under normal
and hypoxic conditions.
Results
Macrophages manifest increased expression of the adhesion phenotype markers following
exposure to hypoxia:
Total RNA isolated from human macrophages cultured under normal and hypoxic
conditions were subjected to real time RT/PCR to determine whether macrophages express
baseline levels of select adhesion phenotype markers including TGF-1, type I collagen, and
VEGF and whether hypoxia regulates this expression. As shown in Figures 1-3, macrophages
express TGF-1, VEGF, and type I collagen and hypoxia resulted in a significant increase in this
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Figure 1: Comparison of TGF-β1 mRNA levels in
human macrophages before and after hypoxia
exposure. Results are representative of the mean of three
independent experiments.

Figure 2: Comparison of VEGF mRNA levels in
human macrophages before and after hypoxia
exposure. Results are representative of the mean of three
independent experiments.

Figure 3: Comparison of type I collagen mRNA levels
in human macrophages before and after hypoxia
exposure. Results are representative of the mean of three
independent experiments.

expression when compared to normoxic conditions [from 11.23 to 14.01 pg TGF-1/g mRNA,
from 2.38 to 10.7 pg VEGF/g mRNA, and from 0.03 to 0.12 pg type I collagen/g mRNA,
respectively; each p<0.05].
Additionally, as shown in Figures 4-5, hypoxia resulted in a significant increase in TGF1 and VEGF protein levels [from 27.7 to 39.1 and from 69.0 to 192.9, respectively; p < 0.05],
when compared to normoxic conditions.
Figure 4: Comparison of TGF-1 protein levels
in human macrophages before and after
hypoxia exposure. Results are representative of
the mean of three independent experiments.
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Figure 5: Comparison of VEGF protein levels in
human macrophages before and after hypoxia
exposure. Results are representative of the mean of
three independent experiments.

Conclusion
The role of macrophages in post-operative adhesion development is not well defined.
During the healing of the peritoneum, macrophage secretory activity is rarely the sole source for
factors involved in peritoneal healing. Many other cell types within the peritoneum, including
other immune cells, fibroblasts, and mesothelial cells, are also involved in this process. In this
study we have shown that macrophages may contribute to the development of adhesions by
expressing the adhesion phenotype markers TGF-1, type I collagen and VEGF. Similar to
normal peritoneal fibroblasts, hypoxia exposure induces a significant increase in TGF-1, type I
collagen and VEGF in human macrophages (1, 28-34). Future studies encompassing additional
factors secreted in macrophages, following surgical trauma, would be a valuable tool to fully
elucidating the role of macrophages in the pathogenesis of post-operative adhesions.
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CHAPTER 3
Silencing TGF-1 and HIF-1 Gene Expression Significantly Decreased the Adhesion
Phenotype Markers in Macrophages
Introduction
In the previous study we have shown that macrophages express basal levels of select
adhesion phenotype markers including TGF-1, type I collagen, and VEGF. Additionally we
have shown that hypoxia further induces the expression of these markers in macrophages. The
objective of this aim is to determine whether TGF-1, type I collagen, and VEGF expression is
mediated by a HIF-1 and/or TGF-1 dependent mechanism following hypoxia exposure. We
hypothesize that surgical-induced hypoxia triggers a pro-inflammatory signal, leading to the
activation and recruitment of resident and infiltrating macrophages to traumatized tissue, which
may contribute to the development of the adhesion phenotype, a process we believe is mediated
by HIF-1 and TGF-1. The rationale of this study was derived from extensive data in our
laboratory and others indicating that HIF-1 mediates multiple stages of peritoneal healing
following hypoxia exposure, and that TGF-1 regulates multiple stages of peritoneal healing.
The significance of this aim is to provide insight into mechanisms involving peritoneal healing
in macrophages. Understanding the nature of these mechanisms in macrophages will further
highlight their role in peritoneal healing and also demonstrate specific mechanisms involved in
the pathogenesis of postoperative adhesions which may lead to the development of better and
more efficacious approaches for treating and/or preventing adhesions.
Design
To accomplish this aim real-time RT-PCR and small interfering RNA (siRNA)
technology were utilized to assess HIF-1TGF-1, type I collagen, and VEGF gene expression
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in response to hypoxia in human macrophages. Macrophages (2.5 X 105) were seeded in a 6well dish (Becton Dickinson, Franklin Lakes, NJ) transfected with 5 μL of Lipofectamine
RNAiMAX Reagent (Invitrogen, Carlsbad, CA; catalogue no. 13778-075) complexed with 150
picomoles of a specific siRNA (HIF-1TGF-1) in standard medium without antibiotics.
Macrophages were then placed in a standard tissue incubator (37°C; 95% air and 5% CO2) for
24-hrs. Following the initial incubation period macrophages were placed under normal (20% O2)
and hypoxic (2% O2) conditions for an additional 24 hrs. Macrophages were collected from
normal and hypoxic cultures, protein and RNA extracted, cDNA synthesized, and analysis
performed.
Total RNA from each group was subjected to real-time RT/PCR to measure HIF1TGF-1, type I collagen, and VEGF mRNA levels. Additionally, western blot analysis was
utilized to correlate HIF-1TGF-1, and VEGF protein with mRNA levels. Collectively, this
experimental design should yield insight into mechanisms involved in the expression of the
adhesion phenotype markers, by macrophages, under normal and hypoxic conditions.
Results
Silencing HIF-1 gene expression significantly decreased TGF-1, VEGF, and type I
collagen expression in human macrophages under hypoxic conditions:
Total RNA isolated from human macrophages cultured under normal and hypoxic
conditions were subjected to real time RT/PCR to determine the effects of hypoxia on HIF-1,
TGF-1, type I collagen, and VEGF expression. As shown in Figures 6-9, hypoxia resulted in a
significant increase in HIF-1, TGF-1, VEGF, and type I collagen expression when compared
to normoxic conditions [from 0.32 to 0.42 pg HIF-1/g mRNA, from 11.23 to 14.01 pg TGF-
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1/g mRNA, from 2.38 to 10.7 pg VEGF/g mRNA, and from 0.03 to 0.12 pg type I
collagen/g mRNA, respectively; each p<0.05]. In contrast, silencing HIF-1 under hypoxic
conditions resulted in a significant decrease in HIF-1, TGF-1, type I collagen, and VEGF
when compared to hypoxia alone without silencing HIF-1 as shown in Figures 6-9 [from 0.42
to 0.21 pg HIF-1/g mRNA, from 14.01 to 5.77 pg TGF-1/g mRNA, from 10.74 to 3.07 pg
VEGF/g mRNA, and from 0.12 to 0.08 pg type I collagen/g mRNA, respectively; each
p<0.05].
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Additionally, total protein isolated from human macrophages cultured under normal and
hypoxic conditions were subjected to Western blot analysis to determine the effects of hypoxia
on TGF-1 and VEGF protein levels. Hypoxia resulted in a significant increase in TGF-1 and
VEGF [from 27.7 to 39.1 and from 69.0 to 192.9, respectively; p < 0.05] when compared to
normoxic conditions, as shown in Figures 10-11. In contrast, silencing HIF-1 gene expression
resulted in a significant decrease in TGF-1 and VEGF [from 39.07 to 23.10 and from 192.87 to
93.90, respectively; p < 0.05] when compared to hypoxic conditions, as shown in Figures 10-11.

Silencing TGF-1 gene expression significantly decreased type I collagen, and VEGF levels in
human macrophages under hypoxic conditions:
As shown in Figures 12-14, hypoxia resulted in a significant increase in TGF-1, VEGF,
and type I collagen expression when compared to normoxic conditions [from 47.53 to 130.30 fg
TGF-1/g mRNA, from 1258.30 to 1655.01 fg VEGF/g mRNA, and from 23.68 to 53.31 fg
type I collagen/g mRNA, respectively; p<0.05]. In contrast, hypoxia with TGF-1 knockdown
resulted in a reversal of the effects of hypoxia, with a significant decrease in TGF-1, VEGF,
and type I collagen when compared to hypoxia alone [from 130.30 to 38.23 fg TGF-1/g
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mRNA, from 1655.01 to 1157.72 fg VEGF/g
mRNA, and from 53.31 to 15.12 fg type I
collagen/g mRNA, respectively; p<0.05).
Conclusion
To

compensate

for

low

oxygen

conditions (hypoxia) cells activate a number of
adaptive responses to stabilize O2 levels to
maintain metabolic, bioenergetic, and redox

Figure 12: Comparison of TGF-1 mRNA
levels in human macrophages following
hypoxia exposure with and without TGF-1
knock down. Results are representative of the
mean of three independent experiments.

demands. HIF-1 is a major transcriptional
regulator of hypoxic stress (85-86). When O2
levels are adequate PHD modifies HIF-1
which leads to polyubiquitination by VHL
(35-37). Thus, modified HIF-1 is a target for
proteosomal destruction by an E3 ubiquitin
ligase. Under hypoxic stress, PHD activity is
diminished,

thereby

stabilizing

Figure 13: Comparison of VEGF mRNA
levels in human macrophages following
hypoxia exposure with and without TGF-1
knock down. Results are representative of the
mean of three independent experiments.

HIF-

1.
Insight into mechanisms regulating
HIF protein has lead to clinical applications in
ischemic disease (35-38). The most prominent
involve

PHD

inhibitors

though

HIF-1

activators/inhibitors are becoming increasingly

Figure 14: Comparison of type I collagen
mRNA levels in human macrophages
following hypoxia exposure with and
without TGF-1 knock down. Results are
representative of the mean of three independent
experiments.

popular (85). In some cases, HIF-1 activation promotes disease progression, while in others,
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HIF inhibitory responses are a part of disease recovery (85). Overall, these findings support a
role for HIF-dependent therapies in preventing adhesion development.
In addition to HIF-1, the TGF- system regulates a plethora of biological processes that
may be involved in peritoneal healing. It has been shown that alterations in TGF- expression
contribute to a broad range of pathologies, including fibrosis and adhesion development (87).
The fibrotic reaction is characterized by an increased production of ECM components, such as
type I collagen, as well as, proliferation, migration and accumulation of various cells (87). Due
to TGF- promiscuity the TGF- signaling pathway has been an attractive target for therapy in a
number of diseases. The therapeutic approach is dependent on the disease and may involve the
inhibition/activation of the pathway. Inhibitory treatments include ligand traps, such as ligandspecific neutralizing antibodies, soluble ligand receptors, antisense-dependent silencing of
ligands and chemical inhibitors that block kinase activity of TGF- receptors (87). Conversely,
increased ligand-dependent signaling may be beneficial for therapeutic purposes. For example,
recombinant human bone morphogenetic proteins (BMPs) activate the bone regenerative
properties of the BMP pathway (87). Additionally, several preclinical studies have assessed the
efficacy of endogenous/synthetic Smad inhibitors, Smad sequestration, or targeting degradation
in several diseases in vitro and in vivo (87). A comprehensive understanding of TGF- signaling
and regulation in additional cell types, including macrophages, will further provide targets for
treatment of diseases caused by malfunctioning of the TGF-β signaling pathway.
In the past, increased understanding of the cellular and molecular events promoting
adhesion formation has led to the identification of many biologically active molecules with the
potential of regulating events that are central to normal peritoneal and adhesion formation (4). In
this study we have shown that hypoxia exposure resulted in a significant increase in HIF-1,
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TGF-1, type I collagen, and VEGF expression in human macrophages. Silencing HIF-1gene
expression under hypoxic conditions resulted in a significant decrease in TGF-1, type I
collagen, and VEGF levels. Additionally, silencing TGF-1 gene expression under hypoxic
conditions resulted in a significant decrease in both type I collagen, and VEGF levels.
Collectively, results from this study has shown that HIF-1and TGF down-regulation will
indeed minimize the expression of TGF-1, type I collagen, and VEGF which provides
additional insight into mechanisms capable of reducing adhesions in vivo. This study validates
HIF-1as well as TGF as a potential target in post-operative adhesion prevention and
directs us towards evaluating similar mechanisms involved in in vivo animal models.
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CHAPTER 4
Macrophages Induce the Adhesion Phenotype in Normal Peritoneal Fibroblasts
Introduction
The inflammatory response activates the innate immune system which stimulates the
recruitment of macrophages from circulation (82-84). Macrophages influence peritoneal healing
by regulating specific factors involved in repair mechanisms. Hypoxia is known to induce
marked changes in these processes by increasing the secretory activity of macrophages, which
elicits angiogenesis, ECM turnover, inflammation, and phagocytosis (78-79, 82-84).
In addition to macrophages, the role of fibroblasts has also been illustrated in wound
healing. More specifically, fibroblasts secrete ECM proteins resulting in wound contraction and
scar formation (88-89). We have shown that hypoxia alters the phenotype of fibroblasts by
altering an array of wound healing processes including a reduction in plasminogen activator
activity (lower tPA and higher PAI-I), increased angiogenesis (VEGF), increased extracellular
matrix deposition (higher type I collagen and fibronectin), increased cytokine production (higher
TGF-1), and reduced apoptosis (higher Bcl and lower Bax), collectively referred to as the
“adhesion phenotype” (1, 11-16).
Coupled with hypoxia, TGF-1 is believed to coordinate macrophage and fibroblast role
in wound healing by its ability to chemotactically recruit fibroblasts and macrophages to the site
of injury, regulate angiogenesis, as well as, tissue remodeling tissue remodeling (43-47). We
have shown that hypoxia increases the expression of TGF1 in multiple cell types which
further supports the role for this cytokine in wound healing (28, 30, 48-50).
The objective of this study is to determine whether macrophages, exposed to hypoxia,
stimulates primary cultures of fibroblasts to acquire the adhesion phenotype. We hypothesized
that surgical-induced hypoxia triggers macrophages to release factors, more specifically TGF-1,
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with the capability of inducing the adhesion phenotype in normal peritoneal fibroblasts by
modulating factors involved in wound healing. The rationale of this study was derived from
extensive data in our laboratory and others indicating that macrophages express TGF-1 and that
hypoxia induces this expression. The significance of this aim will elucidate the cooperative
aspects of cell-to-cell interactions, comprised of macrophage and fibroblasts, that are
representative of in vivo microenvironments.
Design
To accomplish this aim media collected from human macrophages cultured under
hypoxic conditions (2% O2) were used to treat normal peritoneal fibroblasts. Macrophages (1.0
X 107 cells) were cultured in 10 mL of standard media [Dulbecco’s modified media
supplemented with 10% fetal bovine serum (FBS) and 2% of streptomycin and penicillin] under
normal (20%O2) and hypoxic (2% O2) conditions, for 24 hrs.

After 24 hr incubation

macrophages and media were centrifuged at 1800 RPM for 5 min. Media (10 mL) collected
from normal and hypoxic macrophage cultures were used to culture normal peritoneal fibroblasts
(1.0 x 107 cells) under normal oxygen (20% O2) conditions in a standard tissue incubator for 24
hrs. Additionally, human peritoneal fibroblasts (5 X 106) were cultured in a 6-well dish with 0,
12.5, 25, and 50 ng TGF-1 and then placed in a humidified tissue incubator for 24 hours.
Total RNA from each group was subjected to real-time RT/PCR to measure HIF-TGF1, type I collagen, and VEGF mRNA levels. Additionally, western blot analysis was utilized to
correlate TGF-1, type I collagen, and VEGF protein with mRNA levels. Collectively, this
experimental design should yield insight into the role of fibroblasts and macrophages in
peritoneal wound healing, thus emphasizing the synergistic interaction of different cell types
involved in adhesion development.
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Results
Hypoxia treatment resulted in a significant increase in TGF-1 expression in human
macrophages:
As shown in Figures 1 & 4, hypoxia resulted in a significant increase in TGF-1 mRNA
and protein levels [26.8%, respectively; p < 0.05)], when compared to normoxic conditions.
Hypoxia treatment resulted in a significant increase in TGF-1, VEGF, and type I collagen
mRNA levels in normal peritoneal fibroblasts:
As shown in Figure 15, hypoxia resulted in a significant increase in TGF-1 [26.8%; p <
0.05)], VEGF [86.4%; p < 0.05)], and type I Collagen [35.1%; p < 0.05)] when compared to
normoxic conditions.
Figure 15: Hypoxia treatment resulted in a significant
increase in TGF-β1, VEGF, and type I collagen
mRNA levels in human peritoneal fibroblasts:
Comparison of TGF-β1, VEGF, and type I collagen
mRNA levels in normal peritoneal fibroblasts before and
after hypoxia (2% O2) exposure. Results are
representative of the mean of three independent patients.

Hypoxia treatment resulted in a significant increase in TGF-1, VEGF, and type I collagen
protein levels in normal peritoneal fibroblasts:
As shown in Figure 16, hypoxia resulted in an increase in TGF-1 (28.6%), VEGF
(39.0%), and type I collagen (9.8%) protein levels.
Figure 16: Hypoxia treatment resulted in an increase
in TGF-β1, VEGF, and type I collagen protein levels
in human peritoneal fibroblasts: Comparison of TGFβ1, VEGF, and type I collagen protein levels in normal
peritoneal fibroblasts before and after hypoxia (2% O2)
exposure. Results are representative of the mean of
three independent patients.
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Macrophage secretion significantly increased TGF-1, VEGF, type I collagen mRNA levels in
normal peritoneal fibroblasts under hypoxic conditions:
As shown in Figure 17 normal peritoneal fibroblasts cultured with media collected from
macrophages following hypoxia exposure resulted in a significant increase in TGF-1 [11.2%;
p< 0.05)], VEGF [51.2%; p < 0.05)], and type I Collagen [28.8%; p < 0.05)] mRNA levels when
compared to normal peritoneal fibroblasts cultured with media collected from macrophages
cultured under normal conditions.
Figure 17: Macrophage secretion, following
hypoxia exposure, significantly increased
TGF-β1, VEGF, type I collagen mRNA
levels in human peritoneal fibroblasts:
Comparison of TGF- β1, VEGF, and type I
collagen mRNA levels in normal peritoneal
fibroblasts following incubation with media
collected from macrophages cultured under
normal and hypoxic conditions. Results are
representative of the mean of three
independent patients.

Hypoxia treatment resulted in a significant increase in TGF-1, VEGF, and type I collagen
protein levels in normal peritoneal fibroblasts:
As shown in Figure 18, hypoxic-macrophage media resulted in an increase in TGF-1
(47.0 %), VEGF (3.1%), and type I collagen (78.2%) protein levels.
Figure 18: Macrophage secretion, following
hypoxia exposure, significantly increased
TGF-β1, VEGF, type I collagen protein
levels in human peritoneal fibroblasts:
Comparison of TGF-β1, VEGF, & type I
collagen protein levels in normal peritoneal
fibroblasts following incubation with media
collected from macrophages cultured under
normal and hypoxic conditions.
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TGF-β1 regulation is dose-dependent:
Normal peritoneal fibroblasts exposed to
varying concentrations of TGF-1 exhibited a dosedependent response in TGF-1, VEGF, and type-I
collagen mRNA levels (Figure 19A-C). At a low
TGF-1 concentration (12.5 ng TGF-1/mL media),
TGF-1 [(19A) increased from 0.9 to 1.4 pg
TGFg mRNA; p < 0.05)], VEGF [(19B)
increased from 0.6 to 1.6 pg VEGFg mRNA;
p<0.05)], and type I Collagen [(19C) increased from
0.3 to 0.6 pg type I Collagen/g mRNA; p < 0.05)]
were significantly increased when compared to
baseline TGF-1 levels. In contrast, at higher TGF1 concentrations (25 and 50 ng TGF-1/mL
media), TGF-1 [(19C) declined from 1.4 to 1.3 to
1.1 pg TGFg mRNA; p < 0.05)], VEGF
[(19C) declined from 1.6 to 0.9 to 0.2 pg VEGF/g
mRNA; p < 0.05)], and type I Collagen [(19-C) Figure 19: TGF-β1 regulation is
dose-dependent: Comparison of TGFdeclined from 0.6 to 0.5 to 0.3 pg type I Collagen/g β1 (19A), VEGF (19B), & type I
collagen (19C) mRNA levels in human
mRNA; p < 0.05)] mRNA levels were significantly peritoneal fibroblasts in response to
varying TGF-β1 concentrations (0,
reduced when compared to peak (12.5 ng TGF- 12.5, 25, & 50 ng TGF-β1/mL media).
Representative of the mean of three
independent experiments.
1/mL media) TGF-1 levels.
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Conclusion
In the present study normal peritoneal fibroblasts were cultured under normal and
hypoxic conditions. In addition, media collected from macrophage cultures, with and without
hypoxia exposure, was utilized to culture normal human peritoneal fibroblasts. Base-line levels
for adhesion markers varied from patient to patient. Our results indicate similar trends for each
experimental condition. Consistent with previous findings we have shown that TGF-β1, VEGF,
and type I collagen is significantly increased in normal peritoneal fibroblasts following hypoxia
exposure (1). Additionally, this study indicates that macrophage conditioned media encompass
specific factors promoting TGF-β1, VEGF, and type I collagen expression in normal peritoneal
fibroblasts, thus implicating macrophages as a major contributor to the development of the
adhesion phenotype. In this study we suggest that hypoxia-induced TGF-β1 expression mediates
the induction of the adhesion phenotype in normal peritoneal fibroblasts.
This hypothesis has been formulated on the basis of strong preliminary and published
data, which supports the role of TGF-β1 in inflammation, angiogenesis, and extracellular matrix
(ECM) turnover under normal conditions (43-47). Excessive TGF-

exposure exaggerates these

processes thus promoting the development of adhesions (43). We have shown that TGF-β1
regulates VEGF and type I collagen as well as its own expression TGF-β1 regulation occurs by a
dose-dependent mechanism (19, 45, 90, 91, 92). For example, we have shown that a low
concentration (12.5 ng TGF-β1/mL media) of TGF-β1 resulted in increased expression of VEGF
and type I collagen, as well as, TGF β 1 itself. However, higher concentrations of TGF-β1 (25
ng and 50 ng TGF-β1/mL media) resulted in decreased expression of VEGF and type I collagen,
as well as TGF-β1. These findings indicate that TGF-β1 secreted by macrophages, in response
to hypoxia exposure, is partly responsible for the induction of the adhesion phenotype markers,
VEGF and type I collagen, as well as its own expression in normal peritoneal fibroblasts.
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Therefore, this study not only confirms the biphasic response of TGF-β1 in normal peritoneal
fibroblasts but also emphasize its major role in the development of the adhesion phenotype
involving both autocrine and paracrine mechanisms (91).
Collectively, results from this study support the role of fibroblasts and macrophages in
peritoneal wound healing, thus emphasizing the synergistic effect of multiple cells involved in
adhesion development.
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CHAPTER 5
Discussion
To date, minimal insight involving the role of macrophages in post-operative adhesion
development exists. This study is novel because it highlights a role for the innate immune
system in the pathogenesis of peritoneal wound healing and adhesion development. We have
shown that macrophages express basal levels of adhesion phenotype markers: TGF-1, VEGF,
and type I collagen. Hypoxia enhances the expression of TGF-1, VEGF, and type I collagen
through a HIF-1 and TGF-1 dependent mechanism. Additionally, macrophages exposed to
hypoxia release specific factors that are responsible for inducing the adhesion phenotype in
normal peritoneal fibroblasts.

More specifically, hypoxia-induced TGF-1 expression, in

macrophages, mediates this response through a dose-dependent mechanism.
The innate immune system is activated immediately following injury. Subsequent release
of inflammatory mediators drives recruitment of inflammatory cells from circulation. This rapid
response triggers activation and recruitment of resident and infiltrating macrophages to the site
of injury. Hypoxia exaggerates the inflammatory response. Specifically, hypoxia stimulates
numerous cell types, including macrophages, to produce inflammatory mediators, such as TGF, that are paramount to inflammation (82). HIF-1, a major regulator of oxygen deficiency,
mediates TGF-1 expression under hypoxic conditions. Lack of TGF- signaling substantially
diminishes the inflammatory response (83). Hence, TGF-β-deficient SMAD3 knockouts recruit
macrophages poorly into skin wounds (83). Likewise, we have shown that human macrophages
express TGF-1 and hypoxia enhances this expression through a HIF-1 mediated mechanism.
Therefore, results from this study support the role of macrophages in wound healing partially by
their ability to express TGF-1, a major inflammatory cytokine.
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Hypoxia, a result of surgical trauma, also triggers angiogenesis to re-establish oxygen
availability. Neovascularization during granulation tissue formation in wounds is controlled by a
variety of cytokines and growth factors, including TGF-1 and VEGF. VEGF plays a central
role in neovascularization.

TGF-1 induces VEGF expression (45).

Smad3 and HIF-1

cooperate with TGF- to induce VEGF transcription in humans (45). As mentioned previously,
excessive vascularization promotes adhesion viability and therefore therapeutic applications
targeting angiogenic pathways, specifically VEGF, have been explored. There is compelling
evidence linking macrophages to angiogenesis (45, 82-83).

More specifically, in a study

utilizing macrophage-deficient mice abnormal vascularization was observed in macrophagedepleted wound models (82).

Also, treatment of macrophages with anti-VEGF antibody

neutralized the angiogenic activity of human wound fluids in vitro (82). In support of these
findings, our current study reveals that macrophages express basal levels of VEGF and that
hypoxia induces VEGF expression through a HIF-1 and TGF-1-dependent mechanism.
Additionally we have shown that hypoxia-induced TGF-1 expression in macrophages enhances
angiogenic pathways in normal peritoneal fibroblasts.
In addition to macrophages role in angiogenesis we have also shown that macrophages
play an important role in extracellular matrix turnover, a critical process in wound healing. Type
I collagen is the most abundant ECM protein. Collagen synthesis is critically dependent on the
availability of molecular oxygen in tissue culture, animal, and human wound healing
experiments.

Thus, hypoxia promotes collagen deposition.

As mentioned previously, the

balance between the expression of MMPs and TIMPs is critical to normal wound healing.
Hypoxia inhibits the expression of MMPs and increases TIMPs, thus decreasing matrix
degradation and increasing fibrosis. Therefore, increased expression of type I collagen combined
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with decreased proteolytic activity within the peritoneal cavity, under hypoxic conditions,
perpetuates adhesion development. In addition to hypoxia TGF-1 is known to increase type I
collagen expression and decrease MMP expression which furthers promotes adhesion
development.

Similarly, our current study, utilizing macrophage cultures, supports these

findings. We have shown that macrophages express basal levels of type I collagen and that
hypoxia induces type I collagen expression through a HIF-1 and TGF-1-dependent
mechanism.

Additionally we have shown that hypoxia-induced TGF-1 expression in

macrophages enhances collagen deposition by normal peritoneal fibroblasts.
Indeed results from our study highlight an important role of macrophages in the
pathogenesis of peritoneal wound healing. We have shown that peritoneal macrophages regulate
key processes involved in the pathophysiology of post-operative adhesion development including
inflammation, angiogenesis, and ECM turnover through their production of TGF-1, VEGF, and
type I collagen, respectively.

Additionally, we have shown that macrophages exposed to

hypoxia elicit conditions favorable for adhesion development by enhancing the expression of
specific adhesion phenotype markers: TGF-1, VEGF, and type I collagen. HIF-1 and TGF1 mediate hypoxia effects in macrophages. Additionally, we have proven a synergy that exists
between macrophages and normal peritoneal fibroblasts that promotes the development of the
adhesion phenotype.
Further understanding the nature of additional factors and the relative contributions of
macrophages activated by other mechanisms, such as infection and predisposing diseases, may
lead to the development of better and more efficacious approaches for treating and/or preventing
adhesion development.

Surgical trauma, infection, and predisposing diseases, such as

endometriosis, exaggerate the inflammatory response and subsequently lead to macrophage
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recruitment. As we have shown, macrophage responses to hypoxia are central to these events.
Relatively few studies have shown the effects of hypoxia on macrophages in the presence of costimuli, such as LPS and IFN- which may provide further insight in macrophage activity under
these conditions. Future studies in our laboratory would examine the role of these stimuli and
others that are present following tissue trauma and disease including glucose depletion,
accumulation of lactic acid and other metabolic byproducts, and low pH. Examination of
macrophage activity under these conditions may provide a better picture. Once mechanisms are
better understood it would be possible to block their activity or manipulate their involvement in
peritoneal wound healing. Additional co-culture models could be explored to better understand
the synergistic/antagonistic effects that exist amongst different cell populations, which is more
representative of what occurs in vivo. Also, translating these in vitro studies into an animal
model would be advantageous and confirm our current findings.
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Post-operative adhesion development occurs in the vast majority of patients following
abdominal surgery and is a natural occurrence of peritoneal-wound healing. These fibrous bands
may form within the first 5-7 days post-surgery and have the ability to cause a distortion in the
normal anatomical positioning of abdominal organs.

Consequently, adhesions are major

contributors to small bowel obstruction, infertility, and severe pelvic and abdominal pain.
Physiological processes responsible for adhesion formation remain obscure though it is believed
to involve cell migration, proliferation, and differentiation of several cell types including
mesothelial cells, fibroblasts, and inflammatory and immune cells. Substances released from
these cells regulate fibrinolytic activity, tissue remodeling, angiogenesis, and extracellular matrix
turnover, processes that are known to be central to the development of adhesions. Our long-term
goal is to prevent or selectively limit the development of post-operative adhesions. The objective
of this study is to determine the role that macrophages play in the development of post-operative
adhesions.

Our central hypothesis states that surgical-induced hypoxia triggers a pro-

inflammatory signal, leading to the activation and recruitment of resident and infiltrating
macrophages, which contribute to the development of the adhesion phenotype. This hypothesis
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has been formulated on the basis of strong preliminary and published data, which suggest that
hypoxia plays a major role in the development of the adhesion phenotype. Indeed, we have
shown that exposure of normal peritoneal fibroblasts to hypoxia, irreversibly, induces the
adhesion phenotype. This phenotype is characterized by a reduction in plasminogen activator
activity, increased extracellular matrix deposition, increased cytokine production, and reduced
apoptosis. In this study we have shown that macrophages express basal levels of adhesion
phenotype markers: TGF-1, VEGF, and type I collagen. Hypoxia enhances the expression of
TGF-1, VEGF, and type I collagen through a HIF-1 and TGF-1 dependent mechanism.
Additionally, macrophages exposed to hypoxia release specific factors that are responsible for
inducing the adhesion phenotype in normal peritoneal fibroblasts. More specifically, hypoxiainduced TGF-1 expression in macrophages mediates this response through a dose-dependent
mechanism. Collectively, results from this study highlight a role for the innate immune system
in the pathogenesis of peritoneal wound healing and adhesion development.
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